Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 93 results:
Author Title Type [ Year
] Filters: Author is Anastasilakis, Athanasios D [Clear All Filters]
(2014). Denosumab treatment for juvenile Paget's disease: results from two adult patients with osteoprotegerin deficiency ("Balkan" mutation in the TNFRSF11B gene)..
J Clin Endocrinol Metab. 99(3), 703-7.
(2014). The effect of leptin replacement on parathyroid hormone, RANKL-osteoprotegerin axis, and Wnt inhibitors in young women with hypothalamic amenorrhea..
J Clin Endocrinol Metab. 99(11), E2252-8.
(2014). Irisin in patients with nonalcoholic fatty liver disease..
Metabolism. 63(2), 207-17.
(2013). Coexistence of Graves' disease, papillary thyroid carcinoma and unilateral benign struma ovarii: case report and review of the literature..
Metabolism. 62(10), 1350-6.
(2013). Comparative effect of zoledronic acid versus denosumab on serum sclerostin and dickkopf-1 levels of naive postmenopausal women with low bone mass: a randomized, head-to-head clinical trial..
J Clin Endocrinol Metab. 98(8), 3206-12.
(2013). Leflunomide addition in patients with articular manifestations of psoriatic arthritis resistant to methotrexate..
Rheumatol Int. 33(11), 2917-20.
(2013). Parathyroid hormone changes following denosumab treatment in postmenopausal osteoporosis..
Clin Endocrinol (Oxf). 79(4), 499-503.
(2013). Serum vaspin levels in women with and without gestational diabetes mellitus during pregnancy and postpartum..
Cytokine. 61(1), 127-32.
(2012). Acute phase response following intravenous zoledronate in postmenopausal women with low bone mass..
Bone. 50(5), 1130-4.
(2012). Acute transient thyroid swelling following needle biopsy: an update..
Hormones (Athens). 11(2), 147-50.
(2012). Long-term treatment of osteoporosis: safety and efficacy appraisal of denosumab..
Ther Clin Risk Manag. 8, 295-306.
(2012). Normal bone turnover markers in a patient with active Paget's disease of bone: response to treatment with zoledronic acid..
Endokrynol Pol. 63(4), 312-5.
(2012). Papillary thyroid microcarcinoma presenting as lymph node metastasis--a diagnostic challenge: case report and systematic review of literature..
Hormones (Athens). 11(4), 419-27.
(2012). The role of cytokines and adipocytokines in zoledronate-induced acute phase reaction in postmenopausal women with low bone mass..
Clin Endocrinol (Oxf). 77(6), 816-22.
(2012). Is serum IL-17A a useful systemic biomarker in patients with Langerhans cell histiocytosis?.
Mol Ther. 20(1), 6-7.
(2012). Serum osteoprotegerin, RANKL, and Dkk-1 levels in adults with Langerhans cell histiocytosis..
J Clin Endocrinol Metab. 97(4), E618-21.
(2011). Apelin levels in normal pregnancy..
Clin Endocrinol (Oxf). 75(3), 367-71.
(2011). Denosumab and bisphosphonates: rivals or potential "partners"? A "hybrid" molecule hypothesis..
Med Hypotheses. 77(1), 109-11.
(2011). No effect of rosuvastatin in the zoledronate-induced acute-phase response..
Calcif Tissue Int. 88(5), 402-8.
(2011). Oxidized low-density lipoprotein and adiponectin levels in pregnancy..
Gynecol Endocrinol. 27(12), 1070-3.
(2011). Role of wingless tail signaling pathway in osteoporosis: an update of current knowledge..
Curr Opin Endocrinol Diabetes Obes. 18(6), 383-8.
(2011). Serum vaspin levels in normal pregnancy in comparison with non-pregnant women..
Eur J Endocrinol. 164(4), 579-83.
(2011). Targeting the osteoblast: approved and experimental anabolic agents for the treatment of osteoporosis..
Hormones (Athens). 10(3), 174-95.
(2010). Alterations in serum thyroid-related constituents after thyroid fine-needle biopsy: a systematic review..
Thyroid. 20(3), 265-71.
